Literature DB >> 3162266

Pigmentation of the jawbones and teeth secondary to minocycline hydrochloride therapy.

A E Cale1, P D Freedman, H Lumerman.   

Abstract

Oral pigmentation due to minocycline hydrochloride (Minocin) therapy is an unusual and infrequently reported side effect of the drug. This report describes a patient on long-term minocycline therapy who presented with gingival pigmentation. Upon surgical exploration, the gingiva was noted to be normal in color, but the underlying bone was deeply pigmented. Via fluorescent microscopy, minocycline deposition within the alveolar bone was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162266     DOI: 10.1902/jop.1988.59.2.112

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  5 in total

Review 1.  Tetracyclines and bone: Unclear actions with potentially lasting effects.

Authors:  Amy J Warner; Jessica D Hathaway-Schrader; Rena Lubker; Christopher Davies; Chad M Novince
Journal:  Bone       Date:  2022-03-03       Impact factor: 4.626

Review 2.  Medication-Induced Oral Hyperpigmentation: A Systematic Review.

Authors:  Nada O Binmadi; Maram Bawazir; Nada Alhindi; Hani Mawardi; Ghada Mansour; Sana Alhamed; Sarah Alfarabi; Sara Akeel; Soulafa Almazrooa
Journal:  Patient Prefer Adherence       Date:  2020-10-15       Impact factor: 2.711

3.  Staining of palatal torus secondary to long term minocycline therapy.

Authors:  Aravind Buddula
Journal:  J Indian Soc Periodontol       Date:  2009-01

4.  Influence of the bleaching interval on the luminosity of long-term discolored enamel-dentin discs.

Authors:  Lucia K Zaugg; Patrik Lenherr; Judith B Zaugg; Roland Weiger; Gabriel Krastl
Journal:  Clin Oral Investig       Date:  2015-08-09       Impact factor: 3.573

5.  Evaluation of gingival melanin pigmentation in pediatric population- An observational study.

Authors:  Jerusha Santa Packyanathan; G Lavanya
Journal:  J Family Med Prim Care       Date:  2019-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.